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Surgery for congenital mitral valve disease in 
the first year of life 
Between 1980 and 1993, 20 patients less than 1 year of age underwent operations for congenital mitral 
valve disease. Ten patients had congenital mitral incompetence and 10 had congenital mitral stenosis. 
Mean age was 6.6 - 3.4 months and mean weight was 5.6 +_ 1.5 kg. Atrioventricular canal defects, 
univentricular heart, class III/IV hypoplastic left heart syndrome, discordant atrioventricular nd 
ventriculoarterial connections, and acquired mitral valve disease were excluded. Indications for opera- 
tion were intractable heart failure or severe pulmonary hypertension, or both. Associated lesions, present 
in 90% of the patients, had been corrected by a previous operation in seven. In congenital mitral 
incompetence there was normal eaflet motion (n = 3), leaflet prolapse (n = 2), and restricted leaflet 
motion (n = 5). In congenital mitral stenosis anatomic abnormalities were parachute mitral valve (n = 
4), typical mitral stenosis (n = 3), hammock mitral valve (n = 2), and supramitral ring (n = 1). Mitral 
valve repair was initially performed in 19 patients and valve replacement in one with hammock valve. 
Concurrent repair of associated lesions was performed in 12 patients. The operative mortality rate was 
zero. There were six early reoperations in five patients for mitral valve replacement (n = 4), a second 
repair (n = 1), and prosthetic valve thrombectomy (n = 1). One late death occurred 9months after valve 
replacement. Late reoperations for mitral valve replacement (n = 2), aortic valve replacement (n = 1), 
mitral valve repair (n = 2), subaortic stenosis resection (n = 1), and second mitral valve replacement 
(n = 1) were performed in five patients. Actuarial freedom from reoperation is 58.0% - 11.3% (70% 
confidence limits 46.9% to 68.9%) at 7 years. After a mean follow-up of 67.6 _ 42.8 months, 94% of living 
patients are in New York Heart Association class I. Doppler echocardiographic studies among the 13 
patients with a native mitral valve show mitral incompetence of greater'than moderate degree in one 
patient and no significant residual mitral stenosis. Overall, six patients have mitral prosthetic valves with 
a mean transprosthetic gradient of 6.2 +_ 3.7 mm Hg. These results show that surgical treatment for 
congenital mitral valve disease in the first year of life can be performed with low mortality. Valve repair 
is a realistic goal in about 70% of patients and possibly more with increased experience. Reoperation rate 
is still high and is related to complexity of mitral lesions and associated anomalies, but late functional 
results are encouraging. (J THORAC CARDIOVASC SURG 1995;109:164-76) 
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Congen i ta l  mitral valve disease is a rare devel- 
opmental malformation characterized by a wide 
spectrum of morphologic abnormalities and a high 
incidence of associated cardiac anomalies. 1-5 Several 
authors have made important contributions leading 
to significant advances in pathologic, clinical, and 
therapeutic aspects of congenital mitral valve dis- 
ease, but few have focused on the specific issue of 
very early presentation. 6-9Congenital mitral valve 
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Table I. Preoperative clinical data 
Patient Age Weight Type of MV Associated 
No. (mo) (kg) dysfunction anomalies Previous operations 
1 8 6.9 MI DORV 
2 7 6.5 MI Coarctation Coarctectomy 
3 12 6.8 MI ASD 
4 6 6 MI - -  - -  
5 6 4.6 MI PDA 
6 8 5.4 MI AS Aortic commissurotomy 
7 5.5 3.3 MI PDA 
8 9 5.6 MI Coarctation Coarctectomy 
9 10 7.1 MI VSD 
10 2 4.1 MI - -  - -  
11 2.5 4.2 MS VSD (multiple) - -  
12 12 6.8 MS AS 
13 2 3.2 MS AS Closed aortic valvulotomy 
14 6 6.5 MS VSD 
15 2.5 5.1 MS VSD 
16 7 6.3 MS SAS, coarctation Coarctectomy 
17 2 3.9 MS ASD 
18 12 8.8 MS VSD VSD closure 
PDA division 
19 8.5 6 MS SAS, coarctation Coarctectomy 
20 3 4.5 MS DORV, PS - -  
MV, Mitral valve; M/, mitral incompetence; MS,mitral stenosis; DORV, double-outlet right ventricle;ASD, atrial septal defect; PDA, patent ductus;AS, aortic 
stenosis; VSD, ventricular septaI defect; SAS, subaortic stenosis; PS, pulmonary stenosis. 
disease in infancy reflects severeness of the mitral 
valve malformations or associated conditions. Nat- 
ural history in these cases is particularly dismal, with 
death occurring in the first months of life. I°' 11 In 
view of its poor results, surgical treatment for con- 
genital mitral valve disease is always delayed until 
severe symptoms develop with medical treatment 
but may occasionally be unavoidable. Despite ad- 
vances in the treatment of complex congenital heart 
defects in very small infants, congenital mitral in- 
competence (MI) or stenosis (MS) sufficiently se- 
vere to require an operation during the first year of  
life is still a therapeutic challenge. Mitral valve 
repair has been advocated and deemed possible in 
the majority of these patients. 6'i2 However, the 
number of surgically treated infants with congenital 
mitral valve disease is small in any individual insti- 
tutional experience. 
In view of limited information on selection of 
procedures and results in infants operated on for 
congenital mitral valve disease, we have reviewed a 
13-year experience at Our institution. 
Patients and methods 
Patients. From January 1980 through December 1993, 
we have retrospectively reviewed the records of all pa- 
tients less than 1 year of age who were operated on at 
Marie Lannelongue Hospital for congenital MI or MS, 
whether isolated or associated with other congenital mal- 
formations. 
Left atrioventricular valve anomalies associated with 
atrioventricular canal defects, class Ill/IV hypoplastic left 
heart syndrome, atrioventricular discordance, complete 
transposition, straddling mitral valve, univentricular 
atrioventricular connections, and acquired mitral valve 
disease were excluded from this study. Also excluded was 
MI resulting from anomalous origin of the left coronary 
artery. The patients included 15 boys and five girls with a 
mean age of 6.6 _+ 3.4 months (2 to 12 months) and a 
mean weight of 5.6 - 1.5 kg. Ten patients had predomi- 
nant MI (mean age 7.4 _+ 2.7 months) and 10 had 
predominant MS (mean age 5.8 - 3.9 months). 
Preoperative symptoms consisted of congestive heart 
failure, poor growth, and pulmonary hypertension. Oper- 
ation was indicated in the presence of systemic pulmonary 
hypertension or repeated episodes of poorly tolerated 
cardiac failure unresponsive tomedical treatment. Eleven 
patients were in New York Heart Association (NYHA) 
functional class IV (severe heart failure with tachypnea, 
tachycardia, nd hepatomegaly) and nine patients were in 
class III (frequent episodes of pulmonary infection or 
heart failure with underdevelopment). Three patients with 
MI and one with MS were intubated and their lungs were 
mechanically ventilated before the operation. The opera- 
tion was delayed until after 6 months if possible. The 
interval between the onset of symptoms and time of 
operation ranged between 0.5 and 5 months (mean 1.8 
months). 
Seven patients had undergone previous operations. 
Four had coarctation repair, two had aortic commissurot- 
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Table II. Preoperative Doppler echocardiographic and catheterization data in patients with MI  
Echocardiographic data Catheterization data 
MI Annular LA PAP PAP 
Patient degree MI diameter L VEDD L VESD diam LAP syst mean 
No. (1-4) mechanism* (ram) (mm) (ram) (mm) (mm Hg) (mm Hg) (mm Hg) 
1 3 II (AL) 25 35 17.5 30 15 48 30 
2 3 II(AL) 17 41 17 35 - -  - -  - -  
3 4 III 25 42 25 50 15 45 29 
4 3 I 20 38 27 55 16 40 22 
5 3 I 23 33 21 30 24 96 75 
6 3 I . . . . . . .  
7 4 III 21 47 30 30 34 85 72 
8 4 III 20 26 13 33 16 52 45 
9 3 III 24 32 t5 50 14 91 62 
10 4 III 18 32 19 30 6 - -  30 
M1, Mitral incompetence; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; LA, left atrium; LAP, left atrial 
pressure; PAP, pulmonary artery pressure; AL, anterior leaflet. 
*Carpentier's classification. 
omy, and one had VSD closure. Associated anomalies 
were present in all but two patients and are listed in Table 
I. Shone syndrome was present in three patients. 
Two-dimensional echocardiography and Doppler exam- 
ination were performed before the operation. Mitral valve 
structure, papillary muscle architecture, and functional 
analysis of leaflet motion were examined from multiple 
views. Mitral anulus diameter at the hinge points of the 
leaflets was measured from the apical four-chamber view. 
Maximum instantaneous and mean gradients across the 
mitral valve were calculated by the modified Bernoulli 
equation. The degree of MI was estimated by color 
Doppler echocardiography. Cardiac catheterization was 
performed in the majority of patients. Mean systolic 
pulmonary artery pressure was 63.9 -- 20.3 mm Hg. 
Results of preoperative investigations are summarized in
Tables II and III. 
Congenital M1. MI was grade 3/4 or 4/4 in all patients. 
Isolated annular dilatation was the cause of MI in three 
cases, leaflet prolpase in two, and restricted leaflet motion 
in five. Mean mitral anulus diameter was 21.4 mm (range 
7 to 15 mm, Z value > +5 in all patients). The left 
ventricular mean diameter was 36.2 mm (range 26 to 47 
mm), two standard eviations above normal values. 13 
Congenital MS. The inflow obstruction to the left ven- 
tricle was at multiple levels in more than half of the 
patients. Mean mitral anulus diameter was 11.7 mm 
(range 7 to 15 mm), with a Z value ranging from - 1 to -3 .  
Two patients with MS also had mild MI. Figs. 1 and 2 
show two-dimensional echocardiographic v ews of a para- 
chute mitral valve and a hammock mitral valve (patients 
18 and 19). 
During this study, congenital mitral valve disease was 
diagnosed in 24 additional infants (16 MS, 8 MI), four of 
whom underwent operation after 1 year of age and 
therefore are not included in this series. 
Operative findings and surgical technique. All patients 
underwent operation by means of a median sternotomy 
with the aid of hypothermic continuous cardiopulmonary 
bypass. In two cases of congenital MS circulatory arrest 
was used. After aortic crossclamping and infusion of 
cardioplegic solution the mitral valve was exposed through 
the interatrial groove in 15 cases and the interatrial 
septum in four. In one case an extended vertical trans- 
atrial septal approach was used. All mitral valve apparatus 
components were analyzed with the objective of establish- 
ing the mechanisms of MI or MS. Echocardiographic data 
and intraoperative findings correlated well. 
Congenital M1. Annular dilatation was a constant fea- 
ture in this series. Systolic restriction of the posterior 
leaflet caused by short chordae associated with variable 
degrees of leaflet hypoplasia was the most frequent anom- 
aly responsible for MI. Treatment consisted of annulo- 
plasty at either the commissural level or posterior leaflet 
level by standardized techniques. 14-16 Chordal mobiliza- 
tion was performed by resection of intermediary chordae 
or incision of papillary muscle. Prosthetic ring annulo- 
plasty was not used. Before closure of the atrium the 
mitral valve was tested for regurgitation with saline solu- 
tion. A reparative procedure was performed in all patients 
with MI. 
Congenital MS. Parachute mitral valve was the most 
frequent lesion found, followed by commissural fusion, 
short chordae, obliterated interchordal spaces, and dimin- 
ished interpapillary distance (typical mitral stenosis of 
Van Praagh or commissure-papillary muscle fusion of 
36 Carpentier's classification).' Surgical procedures con- 
sisted of resection of supravalvular membrane, commis- 
surotomy, papillary muscle vertical incision, chordal fen- 
estration, muscular esection, and instrumental annular 
dilation. One patient with the so-called hammock mitral 
valve underwent valve replacement with a 19 mm St. Jude 
Medical valve (St. Jude Medical, Inc., St. Paul, Minn.). 
The nine other patients initially had a conservative pro- 
cedure. Intraoperative findings and surgical procedures 
are summarized in Tables IV and V. Mean crossclamp 
time and cardiopulmonary b pass time were 46 and 86 
minutes, respectively. 
Follow-up. Postoperative inquiry was performed be- 
tween January and March 1994 through letters or tele- 
phone calls to the referring pediatric ardiologist. Patients 
were regularly followed up clinically and by Doppler 
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Fig. 1. Subcostal four-chamber two-dimensional echocardiographic view of a parachute mitral valve with 
direct at tachment of the two leaflets into a single papillary muscle (patient 18). LA, Left atrium; RV, right 
ventricle; RA, right atrium; PM, papillary muscle. 
Table III. Preoperative Doppler echocardiographic and catheterization data in patients with MS 
Echocardiographic data Catheterization data 
Mean 
transmitral Anulus PAP PAP 
Patient Level of gradient diameter LAP syst mean 
No. obstruction MS mechanism (ram Hg) (mm) (ram Hg) (ram Hg) (ram Hg) 
11 V, SubV Short chordae, near fused PM - -  - -  - -  62 42 
12 V, SubV Hammock - -  15 18 46 26 
13 V, SubV Short chordae, hypertrophic PM - -  - -  21 58 36 
14 SupraV SMR, short chordae 13 12 19 96 60 
15 V, SubV Parachute 10 13 16 75 56 
16 SupraV, V, SubV Parachute, SMR (Shone) 10 7 18 55 34 
17 V, SubV Short chordae, near fused PM 21 9 - -  - -  - -  
18 V, SubV Parachute 15 13 15 60 45 
19 V, SubV Hammock, SMR, annular hypoplasia 9 13 - -  - -  - -  
20 V, SubV Parachute, SMR 12 12 - -  75 48 
MS, Mitral stenosis; LAP, left atrial pressure; PAP, pulmonary artery pressure; V, valvular; SubV, subvalvular; SupraV, supravalvular; PM, papillary muscle; 
SMR, supramitral ring. 
echocardiographic examination. Two patients from over- 
seas could not be traced after being discharged alive after 
valve repair for MI, one in 1987 and one in 1988 (2 and 3 
months after repair). Mean follow-up time for survivors is 
67.6 + 42.8 months (5 to 134 months).  
Data analysis. Whenever  deemed necessary, dimen- 
sions were transformed to Z values. Survival and freedom 
from other t ime-related events were computed with the 
Kaplan-Meier life table method. 
Results 
Early resu l ts .  No  ear ly  deaths  occur red  in th is  
series. 
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Fig. 2. Four-chamber apical two-dimensional echocardiographic v ew of a hammock mitral valve (patient 
19). Note the direct leaflet a tachment toa posterior papillary muscle with absent chordae. LA, Left atrium; 
LV, left ventricle; 3/I, mitral valve; PM, papillary muscle; RV, right ventricle. 
Congenital ML Seven patients had no or minimal 
MI on Doppler echocardiographic studies before 
discharge from the hospital. Three patients had 
moderate-to-severe residual MI and underwent re- 
operation between 1 and 4 weeks after the first 
operation. Two underwent mitral valve replacement 
with a 19 mm St. Jude Medical valve and one had a 
second valve repair (patients 2, 3, and 10). 
Congenital MS. Among the nine patients who 
initially had a conservative procedure, five had a 
good or satisfactory initial result, with clinical im- 
provement, diminished transmitral gradient, and no 
significant MI. Two patients had residual MS. One 
patient was discharged (patient 18) although she 
had some degree of cardiac failure. One patient with 
parachute mitral valve and double-outlet right ven- 
tricle underwent valve replacement with a 17 mm 
Bj6rk-Shiley prosthesis (Shiley, Inc., Irvine, Calif.) 
placed in a supraannular position 7 days after at- 
tempted repair (patient 20). Two patients had resid- 
ual MI. One was discharged and one patient, with 
parachute mitral valve, required mitral valve re- 
placement at 1 month with a 17 mm Bj6rk-Shiley 
valve for persisting residual MI (patient 15). 
Morbidity. For the majority of patients the post- 
operative course was simple. Mean intubation time 
and intensive care unit stay were 2.2 _+ 1.7 and 4.7 _+ 
3.2 days, respectively, excluding one patient with 
double-outlet right ventricle and parachute mitral 
valve who had a complicated course. This patient 
required a second reoperation for early valve throm- 
bosis, then had mediastinitis, but finally recovered. 
Late results 
Congenital MI. No late deaths occurred in this 
group. One patient required mitral valve replace- 
ment with a 16 mm CarboMedics valve (CarboMed- 
ics, Inc., Austin, Tex.) 3 months after two unsuccess- 
ful attempts to repair an MI resulting from direct 
leaflet-papillary muscle attachment (patient 10). No 
other late reoperations were performed. Overall, 
three patients have had a mitral valve replacement 
and seven a valve repair. At latest follow-up, all 
patients are in NYHA class I, in sinus rhythm, with 
normal growth, and receive no medications other 
than oral anticoagulants (warfarin sodium) for those 
with prosthetic valves. Doppler echocardiographic 
studies at most recent follow-up of patients who had 
a valve repair showed moderate MI in three patients 
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Table IV. Surgical findings and operative techniques in patients with MI 
Patient Age Concomitant 
No. (mo) Surgical findings Mitral valve procedure procedure Early outcome 
1 8 Papillary muscle elonga- Commissural nnuloplasty VSD enlargement, Good, minimal MI 
tion/malposition, AML DORV repair 
prolapse 
2 7 Absent chordae, AML pro- 
lapse, annular dilatation 
3 12 PML indentation, short Indentation closure, section ASD closure 
chordae, annular dilata- of chordae, commissural 
tion annuloplasty 
4 6 Isolated annular dilatation Posterior annuloplasty 
5 6 Isolated annular dilatation Commissural nnuloplasty 
6 8 Isolated annular dilatation Posterior annuloplasty 
7 5.5 PML hypoplasia/retraction, Commissural nnuloplasty 
annular dilatation 
8 9 PML hypoplasia/retraction, 
AML indentation, annu- 
lar dilatation 
9 10 PML retraction, annular 
dilatation 
10 2 Short chordae to AML 
and PML, annular dila- 
tation 
Commissural nnuloplasty 
Leaflet mobilization, inden- 
tation closure, posterior 
annuloplasty 
Leaflet mobilization, com- 
missural annuloplasty 
Papillary muscle incision, 
commissural nnulo- 
plasty 
Residual MI, MVR 
(19 mm) 
Residual MI, MVR 
(19 ram) 
- -  Good, minimal MI 
Ductus division Good, minimal MI 
- -  Good, minimal MI 
Ductus division Good, minimal MI 
VSD closure 
Good, no MI 
Good, minimal MI 
Residual MI, repair 
M/, Mitral incompetence; AML, anterior mitraI leaflet; PML, posterior mitral eaflet; VSD, ventricular septaI defect; ASD, atrial septal defect; MVR, mitral 
valve replacement. 
Table V. Surgical findings and operative techniques in patients with MS 
Patient Age Concomitant 
No. (mo) Surgical findings Mitral valve procedure procedure Early outcome 
11 2.5 Typical MS 
12 12 Hammock 
13 2 Typical MS, fibro- 
elastosis 
14 6 SMR 
15 2.5 Parachute 
16 7 Parachute, SMR, 
fibroelastosis 
17 2 Typical MS 
18 12 Parachute 
19 8.5 Hammock, SMR, 
small mitral anulus 
20 3 Parachute, SMR 
Commissurotomy VSD closure Good 
MVR (19 mm) Aortic commissur- Good 
otomy 
Commissurotomy, PM splitting Aortic commissur- Good 
otomy 
Ring resection VSD closure Good 
Chordal fenestration, PM VSD closure Severe MI, MVR 
splitting (17 mm) 
Ring resection Subaortic resection Good 
Commissurotomy, PM splitting 
Commissurotomy, PM splitting 
Commissurotomy, ring and 
muscular resection 
Commissurotomy, ring resec- 
tion, PM splitting 
Moderate MI 
Residual MS 
Good 
DORV repair Residual MS, 
MVR (17 ram) 
MS, Mitral stenosis; SMR, supramitral ring; MVR, mitral valve replacement; PM, papillary muscle; VSD, ventricular septal defect; DORV, double-outlet right 
ventricle; ML mitral incompetence. 
and mild MI in two patients. Two patients whose 
mitral valve had been replaced with a 19 mm St. 
Jude Medical valve 6 and 7 years previously have 
moderate transprosthetic gradients (Table VI). 
Freedom from reoperation at 7 years is 61.2% (70% 
CL* 45.6% to 76.9%) (Fig. 3). 
* CL = Confidence limits. 
Congenital MS. Four patients underwent late re- 
operation. Indication, type of operation, and inter- 
val from the first intervention are summarized in 
Table VII. One patient outgrew his prosthetic valve 
and underwent a second mitral valve replacement 
(with a prosthesis two sizes larger) 8 years after the 
initial procedure (patient 12). Aortic valve replace- 
ment and mitral valve repair for aortic stenosis and 
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Table VI. Follow-up of patients with MI 
Residual 
mean 
Interval transmittal 
Patient Late from first NYIL4 Medical Residual gradient Follow-up 
No. reoperat ions  operation class treatment MI (ram Hg) (mo) 
1 No - -  I No  2 0 134.5 
2 No  - -  I AVK - -  12 95.5 
(S JM 19) 
3 No  - -  I AVK - -  6 77 
(S JM 19) 
4 No  - -  I No  1 0 85 
5 . . . . . .  Lost  at  2 mo 
6 No - -  I No  2 0 71 
7 . . . . . .  Lost  at  3 mo 
8 No - -  - -  - -  2 5 58 
9 No  - -  I No  1 0 16 
10 MVR 3 mo I AVK - -  2 13 
(Carbo  16) (Carbo  16) 
M/, Mitral incompetence; NYHA, New York Heart Association; MVR, mitral valve replacement; Carbo, CarboMedics valve; AVK oral anticoagulant; SJM, 
St. Jude Medical valve. 
MI were performed in one patient (patient 13). 
Papillary muscle splitting of a parachute mitral 
valve, resection of recurrent supravalvular mitral 
ring, and subaortic myectomy were done in patient 
16. Finally, one patient (patient 18) underwent 
mitral valve replacement for residual MS 9 months 
after conservative treatment of a typical MS. This 
patient required a second valve replacement for 
valve thrombosis and died after unsuccessful throm- 
bolytic therapy for valve rethrombosis. Autopsy 
confirmed the obstruction of the two prosthetic 
leaflets by organized thrombus. At latest follow-up, 
all patients were in NYHA class I except for one 
patient who has a moderate-to-severe residual MI 
and is in class II. Somatic development is normal in 
all patients. Mean native valve residual gradient is 
3.2 _+ 1.6 mm Hg. Pulmonary artery pressures are 
normal or mildly elevated. One patient (patient 16) 
with Shone complex has recurrent subaortic stenosis 
and is scheduled for a Ross operation. Freedom 
from reoperation for congenital MS at 5 years is 
54.8% (70% CL 39.4% to 70.3%) (see Fig. 3). 
Reoperations. In total, five late reoperations were 
performed between 3 months and 8 years after the 
first procedure. Overall actuarial rate of freedom 
from reoperation including early reoperations is 
58% (70% CL 46.9% to 68.9%) at 7 years (see Fig. 
3). Although freedom from reoperation is lower in 
congenital MI than in congenital MS, there is wide 
overlapping of 70% CL. 
Mortality. Overall actuarial survival is 94% (70% 
CL 88% to 100%) at 7 years (Fig. 4). 
Valve-related complications. Overall six patients 
have prosthetic mitral valves and receive warfarin. 
Early postoperative prosthetic valve thrombosis oc- 
curred in two cases, but no late thromboembolic or 
anticoagulant-related complications have been seen. 
One patient had septicemia without valve involve- 
ment. Mean prosthetic valve gradient is 6.2 __ 3.7 
mm Hg at latest follow-up. 
Discussion 
This study reports a 13-year experience with op- 
erations for congenital mitral valve anomalies in the 
first year of life in 20 patients, excluding atrioven- 
tricular canal defects, with no operative deaths and 
one late death. Mitral valve repair was initially 
performed in 19 of 20 patients and freedom from 
reoperation is 58% at 7 years. Limited information 
on congenital mitral valve disease excluding atrio- 
ventricular canal defects, operated on in infants, 
prompted us to review our results. Extreme hetero- 
geneity of mitral valve structure, coexisting anoma- 
lies, patient ages, and era of treatment makes com- 
parisons between series meaningless. Nevertheless, 
operative mortality in small children operated on for 
congenital mitral valve malformations has been 
high, particularly for those with MS or valve replace- 
ment) 1'17-2° Although results have improved in 
recent years, surgical treatment is still a last resort. 
Indeed, valve replacement or even valve reconstruc- 
tion does not claim to be a curative treatment 
restoring a normal valve physiology without sequel- 
ae. 21 It is therefore justified, as in this series, to 
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Fig. 3. Actuarial freedom from reoperation. Freedom from reoperation at7 years is 58% (70% CL 46.9% 
to 68.9%) for the entire group, 61.2% (70% CL 45.6% to 76.9%) for patients with MI, and 54.8% (70% 
CL 39.4% to 70.3%) for patients with MS. 
operate only for severely symptomatic congenital 
mitral valve disease, the isolated cleft or supraval- 
vular mitral ring being the rare exception to this 
rule. 22 
Study population. In this series, associated le- 
sions were present in 80% and 100% of patients 
with congenital MI and MS, respectively. These 
figures conform to reported clinical and anatomic 
series. 1-6 Severe MI after coarctation resection per- 
sisted in our patients, as it does in about a quarter of 
patients with this association of anomalies. 23' 24 Re- 
stricted posterior leaflet motion was the most fre- 
quently encountered MI mechanism, resulting from 
leaflet hypoplasia, short chordae, or left ventricular 
dilatation. In three patients, isolated annular dilata- 
tion was the only detected anomaly, a similar inci- 
dence to that reported by Coles and associates. 2a 
Although hypoplastic left heart syndrome was ex- 
cluded from this study, at least wo patients with MS 
had mitral/aortic anulus and left ventricular dimen- 
sions very close to values under which a biventricu- 
lar repair is deemed unsafe, reflecting a spectrum of 
left-sided obstructive anomalies. 25
Operation and early results. Reparative tech- 
niques for congenital MI in young children must rely 
on some type of segmental nnnloplasty whether at 
the commissural or posterior leaflet level. 14-16'26 
Other reconstructive procedures at the subvalvular 
level, as described by Carpentier and associates, 6 
particularly for leaflet prolapse, may be helpful but 
were not used in this series. Three patients in this 
series (two of them operated on early in the series) 
had early failure of mitral valve repair and required 
valve replacement or a second repair because of 
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Fig. 4. Actuarial survival curve. Actuarial survival at 7 years is 94.1% (70% CL 88% to 100%). 
Table VII. Follow-up of patients with MS 
Patient 
No. 
Residual 
mean 
Interval transmitral 
from first NYHA Medical gradient Follow-up 
Late reoperations operation class treatment Residual M1 (mm Hg) (too) 
11 No - -  I No No 6 127 
12 Second MVR (SJM 23) 8 yr I AVK - -  4 (SJM 23) 120 
13 AVR, MV annuloplasty 9 yr I AVK 1 2 122 
14 No - -  I No No 3 80 
15 No - -  I AVK, diuretics - -  7 (Bj6rk 17) 50 
16 MV repair, SAS resec- 2 yr I No 1-2 2 42, LV/Ao 
tion 90 mm Hg 
17 No - -  II Digoxin, 3-4 4 38 
diuretics 
18 MVR (Carbo 18) 9 mo . . . .  Died at 6 mo 
19 No - -  I No 2 2 15 
20 No - -  - -  AVK No 3 5 
MS, Mitral stenosis; NYHA, New York Heart Association; MI, mitral incompetence; MVR, mitral valve replacement; SJM, St. Jude Medical valve;AVR, aortic 
valve replacement; MV, mitral valve; SAS, subaortic stenosis; Carbo, CarboMedics valve; AV/~ oral anticoagulant; BjOrk, Bj6rk-Shiley valve; LV/Ao, left 
ventricular/aortic gradient. 
anterior leaflet prolapse and short chordae that 
could not be adequately corrected. Recognition of 
unsatisfactory results by intraoperative transesoph- 
ageal echocardiography with infant-sized probes will 
certainly reduce the need for early reoperations 
after mitral valve repair. Surgical correction of MS 
in the first year of life remains a surgical challenge. 
Difficulties arise from poor exposure of the subval- 
vular structures, annular hypoplasia, and left ven- 
tricular muscular crowding. Valvotomy and chordal 
fenestration, together with papillary muscle splitting 
and annular dilation, are undoubtfully useful pallia- 
tive procedures that can result in some reduction in 
mitral valve gradient. 1 Barbero-Marcial nd associ- 
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ates 27 have recently reported a left ventricular apical 
approach for congenital MS with no operative mor- 
tality and no significant residual MS. We have 
recently used an extended superior septal approach 
in a patient with parachute mitral valve that consid- 
erably improved mitral valve exposure, z8Instrumen- 
tal annular dilation was used whenever a diminutive 
anulus obscured subvalvular structures or could not 
accommodate the smallest available prosthetic 
valve. In one patient a 17 mm Bj6rk-Shiley valve had 
to be placed supraannularly. 9 We have not used 
proposed alternatives to treat congenital MS, such 
as left atrial-left ventricular extracardiac conduit or 
mitral ring enlargement with double valve replace- 
ment. 29-31 Some authors have recently used balloon 
angioplasty successfully in seven of nine patients 
with congenital MS, four of whom were less than 1 
year old, but none had parachute mitral valve. 32 
Our repair-oriented policy has resulted in a 25% 
early reoperation rate but allowed for a good result 
in seven of ten cases of repaired congenital MI and 
five of nine cases of congenital MS without mortal- 
ity. The objective, albeit imperfect, was to improve 
the patient's condition enough to avoid valve re- 
placement altogether or at least to postpone it, 
thereby allowing for some annular growth. Indeed, 
although results of mitral valve replacement in early 
childhood have improved, a mortality rate of 30% 
was reported in recent studies. 33'34 Bolling and 
associates 35reported on a series of patients with 
Shone anomaly, with an average of 2.4 operations 
per patient and a 24% mortality. They found that 
severity of mitral valve obstruction correlated in- 
versely with outcome. Noticeably, morphology 
greatly influences the difficulty of conservative treat- 
ment for congenital mitral valve disease during 
infancy. MI with leaflet restriction and MS caused 
by parachute or hammock-type mitral valves are 
particularly demanding. Ad integrum correction 
may be beyond reach in some infants with congen- 
ital mitral valve disease, but better results can be 
expected with increased experience and develop- 
ment of technical refinements. 
Late results. After a mean follow-up of 5.5 years, 
good functional results were obtained in 95% of this 
series of cases. These children are free of symptoms 
and have a normal somatic development. Late fol- 
low-up of patients who underwent repair of congen- 
ital MI shows mild-to-moderate r sidual MI and 
regression of left ventricular dilatation. These re- 
sults compare favorably with the reported 50% to 
60% incidence of valvuloplasty failure after valve 
repair in older children. 2° As could be expected, 
freedom from re0Peration was less common (al- 
though not significantly so) in patients with congen- 
ital MS than in those with congenital MI; late 
reoperations were due to mitral dysfunction or 
associated left heart obstruction. Patients with con- 
genital MS who underwent repair have trivial to 
mild residual MS and normalization of pulmonary 
pressures. Among the six patients who have pros- 
thetic mitral valves in this series, five patients till 
face the risk of a second valve replacement, and one 
has undergone mitral valve replacement with a 
two-size upgrade. 
The retrospective nature of this study, small num- 
ber of patients, and wide spectrum of malformations 
preclude firm conclusions. However, some lessons 
may be drawn. Congenital malformations of the 
mitral valve in infancy are severe and difficult to 
treat, but operations can be performed with low 
mortality. Repair should be attempted and is feasi- 
ble in the majority of cases of MI although less 
predictive in MS. The need for reoperations could 
be reduced with more experience but will remain a 
constant late hazard, particularly in patients with 
MS. Encouragingly, late functional results are good, 
most patients having a normal i fe. 
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Discussion 
Dr. Lari A. Attai (Bronx, N.K). For historic reasons, I 
would like to present the case history of a 31-year survivor, 
a patient with congenital MS, who has undergone three 
prosthetic valve replacements thus far. 
On June 16, 1963, Dr. George Robinson replaced the 
mitral valve of a 10-month-old infant who was born with 
congenital MS. He used the then-available dog model of 
the Starr-Edwards aortic valve prosthesis in the mitral 
position. The procedure was done through a left thora- 
cotomy in an empty, beating heart, which was the ap- 
proach of choice at that time. The infant survived the 
operation and required a second procedure 2 years later 
at 3 years of age. 
The first explanted prosthesis had ingrowth of endocar- 
dial tissue on the atrial side under the apex of the cage. 
The cross-sectional surface of the valve was 0.8 cm 2. The 
second valve, inserted in 1965, was a similar but larger 
prosthesis. Its cross-sectional surface area was 1.5 cm 2. 
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The patient did very well and was married at the age of 
26 years. Incident to her honeymoon in Hawaii and to 
marital activities, she became severely symptomatic again, 
with shortness of breath on exertion, fatigue, and near 
syncopal episodes. Recatheterization showed supersys- 
temic pulmonary hypertension (a pressure of about 140 
mm Hg versus an aortic pressure of 100 mm Hg) and 
significantly reduced cardiac index. 
I reoperated on her in 1985, shortly after her return 
from her honeymoon. This operation was done through a 
right thoracotomy and again--that was in 1965--in an 
empty, warm, beating heart. The third operation was done 
through a median sternotomy and was done through our 
current approach, which is with the aorta crossclamped 
and cardioplegic arrest of the heart. She survived the 
operation and currently is alive and well, enjoying full 
employment and her married life. 
I present his case for historic reasons. This may be the 
longest survival time after valve replacement in a patient 
with congenital MS. This case represents the evolution of 
the surgical approach to mitral valve replacement in 
general and the remarkable durability of the Starr-Ed- 
wards valve, which lasted for 24 years without any struc- 
tural changes in the valve at all. 
Dr. Roland Itetzer (Berlin, Germany). We have been 
following an almost identical concept during the past 6 
years. Since starting our pediatric program in Berlin 6 
years ago, we have operated on 275 atrioventricular valves 
in the pediatric group. Only eight mitral valve replace- 
ments were included in the whole group. Invariably, mitral 
valve replacement was done after two or three previous 
reconstructions. 
This group included 58 patients with nonatrioventricu- 
lar canal type mitral defects. Nine infants were operated 
on at the age of 2 weeks to 1 year. The valve anomalies 
included annular dilatation, Shone complex, parachute 
valve, and abnormal clefts. Various types of repair were 
attempted: suture techniques uch as the Kay-Wooler 
repair or the Paneth repair along the entire posterior 
anulus, papillary muscle splitting, and fenestration. All 
children survived. Four reoperations have been done since 
then, again with mitral repair, because we try to repair the 
mitral valve at all costs. 
I would like to ask you three questions: What degree of 
MI would you accept before reoperating on an infant or a 
small child? What type and what size of prosthesis have 
you used in these children? Which type of abnormality 
would you consider as a primary indication for mitral 
valve replacement in this age group? 
Dr. Sousa Uva. Thank you for your comments and 
questions. Regarding the criteria for reoperation, one 
should consider the degree of MI and the severity of 
symptoms. The indication for reoperation is the associa- 
tion of severe residual MI and persisting debilitating 
symptoms. The same applies for MS. 
Regarding the size of prosthesis, we have inserted two 
17 mm Bj6rk-Shiley valves, one of them supraannularly. 
The remaining are bileaflet valves (St. Jude Medical and 
CarboMedics) ranging between 16 mm and 19 mm. One 
patient has had a second valve replacement, and the 
original 19 mm St. Jude Medical valve was replaced by a 
23 mm St. Jude Medical valve. 
The wide morphologic spectrum of congenitally mal- 
formed mitral valves makes it difficult to codify pathologic 
types. It is important to carefully analyze all components 
of the mitral valve before deciding whether to repair or to 
replace the valve. Hammock mitral valve and some para- 
chute mitral valves are beyond the possibilities of repair, 
and valve replacement may be unavoidable. Regurgitant 
mitral valves with restricted leaflet motion and leaflet 
hypoplasia can sometimes be a technical challenge, par- 
ticularly when there is direct leaflet-papillary muscle 
attachment with very short or absent chordae. Intraoper- 
ative transesophageal chocardiography may well prove to 
be an important adjunct for the management of these 
infants undergoing mitral valve surgery. Intraoperative 
evaluation of valve repair will probably increase the 
indications for conservative treatment and reduce the 
incidence of early reoperations. 
A perfect repair is almost always impossible to achieve 
in these patients. The objective is to improve the patient's 
clinical condition. This improvement is frequently synon- 
ymous with a normal life for a long time and, if valve 
replacement is ultimately required, annular growth has 
allowed for implantation of a larger mitral prosthesis. 
Dr. Edward L. Bove (Ann Arbor, Mich.). The most 
challenging roup for most of us are the infants with 
isolated congenital MS. If I understood your data cor- 
rectly, five of your patients with isolated MS had good 
results. Presumably in one or more of those the primary 
abnormality was a supravalvular mitral ring. Did these 
patients have any other unifying morphologic haracter- 
istics? 
Dr. Sousa Uva. Ten patients had predominant MS. 
Among them there were four patients who had a mem- 
branous upravalvular ring, but in only one case there was 
an isolated supravalvular ring. In the other cases a mem- 
branous ring was associated with a parachute mitral valve 
or a Hammock mitral valve. Thus there was only one in 
which the procedure consisted of a pure resection of the 
membranous ring. 
Dr. Bove. How many of those patients had good results 
with just a commissurotomy? 
Dr. Sousa Uva. The only patient with isolated mitral 
ring is doing fine. 
Dr. Bove. How many of those patients without supra- 
valvular mitral rings is what I was asking. 
Dr. Sousa Uva. Only one patient had a simple commis- 
surotomy. 
Dr. William G. Williams (Toronto, Ontario, Canada). 
The congenitally stenotic mitral valve is a problem be- 
cause the chordae are not merely short, they are nonex- 
istent. The papillary muscles tend to fuse with the leaflets. 
Have you any technical tricks to deal with that situation, 
or do you simply compromise and open the leaflets as 
much as possible from above? 
Dr. Sousa Uva. One of the important issues is to 
determine the best route by which to approach the mitral 
valve: through the interatrial groove, the interatrial sep- 
turn, or, as reported recently by a Brazilian group, through 
a left ventricular approach. Most of the time we have 
approached the mitral valve through the interatrial groove 
and occasionally through the interatrial septum. Recently 
we have used an extended superior septal approach, which 
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has considerably improved the exposure. Good mitral 
valve exposure is crucial for an appropriate anatomic 
analysis and for adequate access to the subvalvular level. 
About the surgical tricks, we start by doing commissur- 
otomy and annular dilation to improve the exposure of the 
subvalvular apparatus. Then we perform chordal fenestra- 
tion and papillary muscular splitting, keeping in mind that 
we cannot be too ambitious because of the risk of creating 
severe mitral regurgitation. The idea is to improve the 
gradient enough for the patient's condition to improve 
without creating iatrogenic mitral regurgitation. 
I would like to stress that balloon valvuloplasty repre- 
sents another option for patients with MS. The group 
from Boston Children's Hospital has reported this kind of 
treatment in some patients with MS; however, none of 
those patients had parachute mitral valve, which is con- 
sidered a contraindication to balloon valvuloplasty. Some 
patients may be amenable to percutaneous intervention, 
but the indications and results of balloon valvuloplasty are 
not yet clearly established. 
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